|
|
Article: The U.S. Food and Drug Administration Approves Actonel(R) With Calcium.
- Article from:
- PR Newswire
- Article date:
- August 15, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CINCINNATI, Ohio and BRIDGEWATER, N.J., Aug. 15, 2005 /PRNewswire/ -- On Friday, August 12, 2005, the U.S. Food and Drug Administration (FDA) approved Actonel with Calcium (risedronate sodium tablets with calcium carbonate tablets, USP), a product that provides the fracture protection of Actonel tablets conveniently packaged with calcium tablets. Actonel with Calcium is the first prescription osteoporosis therapy to include calcium.
"Osteoporosis is a serious, widespread and growing public health threat," said Judith Cranford, Director, National Osteoporosis Foundation. "The NOF welcomes any new FDA approved treatment options, such as Actonel with Calcium, that ...